The Global Radiopharmaceutical market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Radiopharmaceutical in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Radiopharmaceutical Players in each region, with sales, price, revenue and market share for top 5 manufacturer, covering Bayer Triad Isotopes Lantheus GE Healthcare Mallinckrodt Eli Lilly Bracco Imaging SIEMENS Navidea Nordion IBA Group Jubilant Pharma Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top 5 players in these regions, from 2012 to 2017 (forecast), like North America (United States, Canada and Mexico) Asia-Pacific (China, Japan, Southeast Asia, India and Korea) Europe (Germany, UK, France, Italy and Russia etc. South America (Brazil, Chile, Peru and Argentina) Middle East and Africa (Egypt, South Africa, Saudi Arabia) Split by Product Types, with sales, revenue, price, market share of each type, can be divided into Diagnostic Radioisotopes Therapeutic Radioisotopes Split by applications, this report focuses on sales, market share and growth rate of Radiopharmaceutical in each application, can be divided into Oncology Cardiology Other
Table of Contents 2017 Top 5 Radiopharmaceutical Manufacturers/Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa 1 Radiopharmaceutical Market Overview 1.1 Product Overview and Scope of Radiopharmaceutical 1.2 Radiopharmaceutical Segment by Types 1.2.1 Global Sales Market Share of Radiopharmaceutical by Types in 2016 1.2.2 Diagnost